Evidence map›Paper›PMID 29144507›Full record

ArticleCell death & disease2017

The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells.

Francesca Zalfa, Vincenzo Panasiti, Simone Carotti, Maria Zingariello, Giuseppe Perrone, Laura Sancillo, Laura Pacini, Flavie Luciani, Vincenzo Roberti, Silvia D'Amico and 12 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Comprehensive Analysis of N6-Methyladenosine (mCanadian journal of gastroenterology & hepatology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 4 countries.

Francesca ZalfaDepartment of Medicine, Campus Bio-Medico University, via Alvaro del Portillo 21, 00128 Rome, Italy.
Vincenzo PanasitiDepartment of Medicine, Campus Bio-Medico University, via Alvaro del Portillo 21, 00128 Rome, Italy.
Simone CarottiDepartment of Medicine, Campus Bio-Medico University, via Alvaro del Portillo 21, 00128 Rome, Italy.
Maria ZingarielloDepartment of Medicine, Campus Bio-Medico University, via Alvaro del Portillo 21, 00128 Rome, Italy.
Giuseppe PerroneDepartment of Medicine, Campus Bio-Medico University, via Alvaro del Portillo 21, 00128 Rome, Italy.
Laura SancilloDepartment of Medicine and Science of Aging, University of Chieti 'G d'Annunzio', via dei Vestini 31, 66100 Chieti-Pescara, Italy.
Laura PaciniDepartment of Biomedicine and Prevention, University of Rome 'Tor Vergata', via Montpellier 1, 00133 Rome, Italy.
Flavie LucianiVIB/Center for the Biology of Disease, KU Leuven, O&N 4, Herestraat 49 Box 602, 3000, Leuven, Belgium.
Vincenzo RobertiDepartment of Dermatology, University of Rome 'La Sapienza', viale dell'Università 1, 00185 Rome, Italy.
Silvia D'AmicoDepartment of Biomedicine and Prevention, University of Rome 'Tor Vergata', via Montpellier 1, 00133 Rome, Italy.
Rosa CoppolaDepartment of Medicine, Campus Bio-Medico University, via Alvaro del Portillo 21, 00128 Rome, Italy.
Simona Osella AbateDepartment of Medical Science and Human Oncology, Section of Dermato-Oncology, University of Turin, via Verdi 8, 10124 Turin, Italy.
Rosa Alba RanaDepartment of Medicine and Science of Aging, University of Chieti 'G d'Annunzio', via dei Vestini 31, 66100 Chieti-Pescara, Italy.
Anastasia De LucaDepartment of Biomedicine and Prevention, University of Rome 'Tor Vergata', via Montpellier 1, 00133 Rome, Italy.
Mark FiersVIB/Center for the Biology of Disease, KU Leuven, O&N 4, Herestraat 49 Box 602, 3000, Leuven, Belgium.
Valentina MelocchiISBREMIT, Institute for Stem-cell Biology, Regenerative Medicine and Innovative Therapies, IRCCS Casa Sollievo della Sofferenza, viale Padre Pio 7, 71013 San Giovanni Rotondo (FG), Italy.
Fabrizio BianchiISBREMIT, Institute for Stem-cell Biology, Regenerative Medicine and Innovative Therapies, IRCCS Casa Sollievo della Sofferenza, viale Padre Pio 7, 71013 San Giovanni Rotondo (FG), Italy.
Maria Giulia FaraceDepartment of Biomedicine and Prevention, University of Rome 'Tor Vergata', via Montpellier 1, 00133 Rome, Italy.
Tilmann AchselVIB/Center for the Biology of Disease, KU Leuven, O&N 4, Herestraat 49 Box 602, 3000, Leuven, Belgium.
Jean-Christophe MarineVIB/Center for the Biology of Disease, KU Leuven, O&N 4, Herestraat 49 Box 602, 3000, Leuven, Belgium.
Sergio MoriniDepartment of Medicine, Campus Bio-Medico University, via Alvaro del Portillo 21, 00128 Rome, Italy.
Claudia BagniDepartment of Biomedicine and Prevention, University of Rome 'Tor Vergata', via Montpellier 1, 00133 Rome, Italy.
Università Campus Bio-Medico · ITUniversity of Rome Tor Vergata · ITVIB-KU Leuven Center for Cancer Biology · BECasa Sollievo della Sofferenza · ITUniversity of Chieti-Pescara · ITDepartment of Medical Sciences · BYSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fragile X mental retardation protein (FMRP) is lacking or mutated in patients with the fragile X syndrome (FXS), the most frequent form of inherited intellectual disability. FMRP affects metastasis formation in a mouse model for breast cancer. Here we show that FMRP is overexpressed in human melanoma with high Breslow thickness and high Clark level. Furthermore, meta-analysis of the TCGA melanoma data revealed that high levels of FMRP expression correlate significantly with metastatic tumor tissues, risk of relapsing and disease-free survival. Reduction of FMRP in metastatic melanoma cell lines impinges on cell migration, invasion and adhesion. Next-generation sequencing in human melanoma cells revealed that FMRP regulates a large number of mRNAs involved in relevant processes of melanoma progression. Our findings suggest an association between FMRP levels and the invasive phenotype in melanoma and might open new avenues towards the discovery of novel therapeutic targets.

Indexed as

Fragile X Messenger Ribonucleoprotein 1HumansMelanomaNeoplasm InvasivenessTransfectionFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID29144507
PMCPMC5775405
OpenAlexW2768681263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.